Eric Tousset
University of Liège
28 Papers
244 Citations
Eric Tousset is an academic researcher from University of Liège. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 12, co-authored 25 publications.
Chat about Author
Papers
Successful Projection of the Time Course of Drug Concentration in Plasma During a 1-Year Period From Electronically Compiled Dosing-Time Data Used as Input to Individually Parameterized Pharmacokinetic Models
TL;DR: Estimated individual pharmacokinetic parameters were then combined with electronic dosing histories to project each patient's internal drug exposure over long periods of time to provide a basis for greatly increasing the informational yield and utility of conventional therapeutic drug monitoring.
97
Innovative ICT solutions to improve treatment outcomes for depression: the ICT4Depression project
Lisanne Warmerdam,Heleen Riper,Michel C. A. Klein,Pepijn van de Ven,Artur Rocha,Mario Ricardo Henriques,Eric Tousset,Hugo Silva,Gerhard Andersson,Pim Cuijpers +9 more
- 01 Jan 2012
TL;DR: An ICT-based system for use in primary care that aims to improve access as well as actual care delivery for depressed adults and test the feasibility and acceptability of the ICT4D system within a pilot study in the Netherlands and in Sweden during 2012 and 2013.
Effects on blood pressure and cardiovascular risk of variations in patients' adherence to prescribed antihypertensive drugs: role of duration of drug action
Andrew M. Lowy,V. C. Munk,S. H. Ong,Michel Burnier,Bernard Vrijens,Eric Tousset,John Urquhart +6 more
TL;DR: The effects of imperfect adherence, and the influence of rate of loss of antihypertensive effect during treatment interruption, on the predicted clinical effectiveness of anti Hypertensive drugs in reducing mean systolic blood pressure (SBP) and cardiovascular disease (CVD) risk are studied.
46
Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics
TL;DR: The data indicate that when applied to HIV protease inhibitors, a twice-daily regimen appears to be better than an once- daily regimen in maintaining therapeutically effective drug actions.
41
Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
TL;DR: Drug adherence improved initially with the use of supportive measures, but this effect faded with time mainly because of the short-lived improvement in the quality of execution achieved, which did not translate into a persistent improvement of medication adherence.
34